Justin Zamirowski
CIK 1888814 · Chief Commercial Officer · last filed 2022-06-01
Justin Zamirowski is a Chief Commercial Officer who has filed 3 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing shows the insider exercised options covering $838 of BTTX on Jun 1, 2022.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
3
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Better Therapeutics, Inc. (BTTX) Delisted | Chief Commercial Officer | 36,913 | $0.04 | $1.6K | $0 | 3 | 2022-06-01 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-01 | Better Therapeutics, Inc. (BTTX) Delisted | Exer (M) | +1,677 | $838 | EDGAR |
| 2022-05-18 | Better Therapeutics, Inc. (BTTX) Delisted | Exer (M) | +35,236 | $17.6K | EDGAR |
| 2022-04-04 | Better Therapeutics, Inc. (BTTX) Delisted | Grant (A) | — | $0 | EDGAR |